Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Brazilian Pharmaceutical Exports to GCC up 73 Per Cent to Reach Over USD 7.4 Million in 2012

Published: Monday, May 13, 2013
Last Updated: Monday, May 13, 2013
Bookmark and Share
ABCC underlines huge long-term growth potential as many GCC countries remain under-served.

Brazil exported USD 7.48 million worth of pharmaceutical products to the GCC in 2012, increasing by over 73 per cent compared to USD 4.31 million in 2011 according to figures released by the Arab Brazilian Chamber of Commerce (ABCC).

The Kingdom of Saudi Arabia and the UAE accounted for the biggest share of the Brazilian pharmaceutical exports at 57.02 per cent and 41.61 per cent, respectively.

The total pharmaceutical exports to KSA surged by 95.63 per cent in 2012 to reach USD 4.26 million from USD 2.18 million in 2011, while exports to the UAE were valued at USD 3.11 million, up 56.28 per cent from USD 1.99 million in 2011.

The top Brazilian pharmaceutical products that are exported to the region include antibiotics, dental products and vaccines for veterinary use.

The Arabian Gulf region ranks 44th among the top export destinations of Brazilian pharmaceutical products, but the Arab Brazilian Chamber of Commerce believes this presents a huge window of opportunity for Brazilian exporters to further expand their trade activities in the region.

Michel Alaby, General Secretary and CEO of Arab Brazilian Chamber of Commerce, said: “The dramatic increase in the value of pharmaceutical exports to the GCC clearly demonstrates the strategic importance of the Gulf region as a key trade partner of Brazil. KSA and the UAE, two of the biggest economies in the region, are particularly important and highly influential markets. Moreover, while the recent figures point to the robust growth performance of Brazilian pharmaceutical exports, it also underlines a huge potential to further expand our regional presence by opening new trade routes in other Gulf countries. Arab Brazilian Chamber of Commerce will therefore play an important role in connecting Brazilian exporters to key players in the GCC’s highly lucrative pharmaceutical market.”

Brazil has been a leading global supplier of pharmaceutical products with 10 of the world’s biggest pharmaceutical companies - Pfizer (United States), Novartis (Switzerland), Sanofi-Aventis (France), Roche (Switzerland), Medley (France), AstraZeneca (Anglo Swedish), EMS Sigma Pharma (Brazil), Eurofarma (Brazil), Aché (Brazil) and Merck (Germany) - having established manufacturing facilities in the country.

Brazil’s global exports of pharmaceutical products amounted to USD 2.98 billion in 2012 with Denmark, Venezuela, United States, Argentina and Mexico among its biggest global markets.

The Arab-Brazilian Chamber of Commerce has been established to consolidate and expand partnerships, generate opportunities and bring Arabs and Brazilians together.

It has been in operation for more than 50 years, playing an active role in boosting economic, cultural and tourism activities, and facilitating the flow of information between Arabs and Brazilians.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
New Diabetes Drug has Unexpected Side Effect
A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease, according to new research.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Cannabis May Be Used to Treat Fractures
TAU researcher finds non-psychotropic compound in marijuana can help heal bone fissures.
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Global Search for Next Antibiotic
University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!